The AstraZeneca/Oxford coronavirus vaccine has been given emergency approval by regulatory agencies in the United Kingdom, the European Union, India, and, on Thursday, South Korea.
But it is unavailable to Americans, and some are arguing AstraZeneca should submit the paperwork for an emergency use authorization immediately in the United States and that the Food and Drug Administration should approve it.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.